This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Amin, J. Articles by Ito, S. Search for Related Content PubMed PubMed Citation Articles by Amin, J. Articles by Ito, S.

(Hypertension. 1996;27:684-687.)
© 1996 American Heart Association, Inc.

Articles

Mechanisms of Action of Atrial Natriuretic Factor and C-Type Natriuretic Peptide

Janki Amin; Oscar A. Carretero; Sadayoshi Ito

From the Hypertension and Vascular Research Division, Department of Internal Medicine and Heart and Vascular Institute, Henry Ford Hospital, Detroit, Mich.

Correspondence to Janki Amin, MD, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202.

Abstract After secretion by the heart, atrial natriuretic factor (ANF) circulates in plasma, whereas C-type natriuretic peptide (CNP), which is found in abundance in the endothelium, may regulate vascular tone in a paracrine manner. However, there is little information on the effect of CNP on renal microvessels. We hypothesized that CNP dilates the afferent arteriole via the nitric oxide pathway, whereas ANF acts directly on vascular smooth muscle cells. When we perfused rat kidneys with minimal essential medium and bovine serum albumin at 100 mm Hg and examined the juxtamedullary afferent arterioles, neither CNP nor ANF was found to have any effect. When the peptides were added to arterioles preconstricted with norepinephrine, CNP and ANF dilated them in a similar fashion; diameters increased by 25±4% (n=7) and 29±6% (n=6) at 10^-7 mol/L, respectively (P<.008). Pretreatment with 10^-4 mol/L N-nitro-L-arginine methyl ester (L-NAME) or 5x10^-6 mol/L indomethacin blocked CNP-induced dilation; dilation by ANF was unaffected by indomethacin (52±25%, n=5) and potentiated by L-NAME (73±14%, n=5). Thus, CNP dilates the afferent arterioles via the prostaglandin/nitric oxide pathway, whereas ANF dilates them directly. This difference may be important in controlling glomerular hemodynamics.

Key Words: nitric oxide • prostaglandins • renal hemodynamics

This article has been cited by other articles:

				A. Simon, E. O. Harrington, G. X. Liu, G. Koren, and G. Choudhary Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L248 - L256. [Abstract] [Full Text] [PDF]

				A. Jankowska, B. Burczynska, T. Duda, J. B. Warchol, and R. K. Sharma Calcium-Modulated Rod Outer Segment Membrane Guanylate Cyclase Type 1 Transduction Machinery in the Testes J Androl, January 1, 2007; 28(1): 50 - 58. [Abstract] [Full Text] [PDF]

				P. S. Andrew and S. Kaufman Guanylyl cyclase mediates ANP-induced vasoconstriction of murine splenic vessels Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1567 - R1571. [Abstract] [Full Text] [PDF]

				P. J.M Best, J. C Burnett Jr., S. H Wilson, D. R Holmes Jr., and A. Lerman Dendroaspis natriuretic peptide relaxes isolated human arteries and veins Cardiovasc Res, August 1, 2002; 55(2): 375 - 384. [Abstract] [Full Text] [PDF]

				F. Brunner and G. Wolkart Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature Cardiovasc Res, August 15, 2001; 51(3): 577 - 584. [Abstract] [Full Text] [PDF]

				P. W. Wennberg, V. M. Miller, T. Rabelink, and J. C. Burnett Jr. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1618 - H1621. [Abstract] [Full Text] [PDF]

				R. L. Woods and M. J. M. Jones Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1443 - R1452. [Abstract] [Full Text] [PDF]

				C. Zellner, A. A. Protter, E. Ko, M. R. Pothireddy, T. DeMarco, S. J. Hutchison, T. M. Chou, K. Chatterjee, and K. Sudhir Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1049 - H1057. [Abstract] [Full Text] [PDF]

				P. Beaulieu, R. Cardinal, P. Page, F. Francoeur, J. Tremblay, and C. Lambert Positive chronotropic and inotropic effects of C-type natriuretic peptide in dogs Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1933 - H1940. [Abstract] [Full Text] [PDF]